Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Unicycive Therapeutics, Inc. UNCY
$1.39
-$0.08 (-5.44%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
23236598.00000000
-
week52high
2.87
-
week52low
0.40
-
Revenue
951000
-
P/E TTM
-1
-
Beta
0.00000000
-
EPS
-1.14000000
-
Last Dividend
0.00000000
-
Next Earnings Date
31 мар 2023 г. в 07:00
Описание компании
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| HC Wainwright & Co. | Buy | 08 июн 2022 г. | |
| Maxim Group | Buy | 16 мар 2022 г. | |
| Roth Capital | Buy | 09 авг 2021 г. | |
| HC Wainwright & Co. | Buy | Buy | 28 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Gupta Shalabh K. | A | 202279 | 86000 | 21 ноя 2022 г. |
| Jermasek Douglas | A | 155000 | 55000 | 21 ноя 2022 г. |
| Townsend John | A | 76861 | 35000 | 21 ноя 2022 г. |
| Gupta Pramod | A | 219862 | 28000 | 21 ноя 2022 г. |
| Schiller Brigitte | D | 0 | 26738 | 15 июл 2022 г. |
| Schiller Brigitte | A | 26738 | 26738 | 15 июл 2022 г. |
| Schiller Brigitte | A | 15000 | 15000 | 16 мая 2022 г. |
| Gupta Shalabh K. | A | 218023 | 116279 | 15 июл 2021 г. |
| Townsend John | A | 41861 | 18605 | 15 июл 2021 г. |
| Gupta Pramod | A | 191862 | 34884 | 15 июл 2021 г. |
Новостная лента
Unicycive to Participate in Upcoming Investor Conferences
GlobeNewsWire
28 ноя 2022 г. в 07:00
Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction
Unicycive Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference
GlobeNewsWire
06 сент 2022 г. в 07:00
Presentation to Highlight Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction Presentation to Highlight Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of Mitochondrial Dysfunction